Contrast injector firm Medrad has received Food and Drug Administration clearance for its SimpliCT interventional guidance system. SimpliCT uses a laser beam to improve accuracy of CT-guided puncture procedures, according to the Indianola, PA-based firm. Medrad is the exclusive distributor of SimpliCT, which is manufactured by Norwegian firm NeoRad.
By AuntMinnie.com staff writersJune 27, 2001
Related Reading
Medrad lands RPI deal, May 10, 2001
Medrad adapts Spectris for mobile use, March 14, 2001
Medrad enhances syringe kits, February 21, 2001
Medrad to distribute CT-Guide, January 24, 2001
Copyright © 2001 AuntMinnie.com



















![Images show the pectoralis muscles of a healthy male individual who never smoked (age, 66 years; height, 178 cm; body mass index [BMI, calculated as weight in kilograms divided by height in meters squared], 28.4; number of cigarette pack-years, 0; forced expiratory volume in 1 second [FEV1], 97.6% predicted; FEV1: forced vital capacity [FVC] ratio, 0.71; pectoralis muscle area [PMA], 59.4 cm2; pectoralis muscle volume [PMV], 764 cm3) and a male individual with a smoking history and chronic obstructive pulmonary disorder (COPD) (age, 66 years; height, 178 cm; BMI, 27.5; number of cigarette pack-years, 43.2, FEV1, 48% predicted; FEV1:FVC, 0.56; PMA, 35 cm2; PMV, 480.8 cm3) from the Canadian Cohort Obstructive Lung Disease (i.e., CanCOLD) study. The CT image is shown in the axial plane. The PMV is automatically extracted using the developed deep learning model and overlayed onto the lungs for visual clarity.](https://img.auntminnie.com/mindful/smg/workspaces/default/uploads/2026/03/genkin.25LqljVF0y.jpg?auto=format%2Ccompress&crop=focalpoint&fit=crop&h=112&q=70&w=112)